within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J05A_DirectActingAntivirals.J05AR06_EmtricitabineTenofovirDisoproxilAndEfavirenz;
model EmtricitabineTenofovirDisoproxilAndEfavirenz 
   extends Pharmacolibrary.Drugs.ATC.J.J05AR06;

  annotation(Documentation(
    info ="<html><body><p>A fixed-dose combination of three antiretroviral medications: emtricitabine (a nucleoside reverse transcriptase inhibitor), tenofovir disoproxil fumarate (a nucleotide reverse transcriptase inhibitor), and efavirenz (a non-nucleoside reverse transcriptase inhibitor). Used for the treatment of HIV-1 infection in adults and children and is currently approved for use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy HIV-negative adults receiving a single oral fixed-dose combination tablet (emtricitabine 200 mg, tenofovir disoproxil fumarate 300 mg, efavirenz 600 mg) under fasting conditions.</p><h4>References</h4><ol><li><p>Dando, TM, &amp; Wagstaff, AJ (2004). Emtricitabine/tenofovir disoproxil fumarate. <i>Drugs</i> 64(18) 2075–2084. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200464180-00005&quot;>10.2165/00003495-200464180-00005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15341498/&quot;>https://pubmed.ncbi.nlm.nih.gov/15341498</a></p></li><li><p>Nirogi, R, et al., &amp; Mukkanti, K (2012). Pharmacokinetic profiling of efavirenz-emtricitabine-tenofovir fixed dose combination in pregnant and non-pregnant rats. <i>Biopharmaceutics &amp; drug disposition</i> 33(5) 265–277. DOI:<a href=&quot;https://doi.org/10.1002/bdd.1794&quot;>10.1002/bdd.1794</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22610784/&quot;>https://pubmed.ncbi.nlm.nih.gov/22610784</a></p></li><li><p>Mathias, AA, et al., &amp; Kearney, BP (2007). Bioequivalence of efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen. <i>Journal of acquired immune deficiency syndromes (1999)</i> 46(2) 167–173. DOI:<a href=&quot;https://doi.org/10.1097/QAI.0b013e3181427835&quot;>10.1097/QAI.0b013e3181427835</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17667331/&quot;>https://pubmed.ncbi.nlm.nih.gov/17667331</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end EmtricitabineTenofovirDisoproxilAndEfavirenz;
